Novavax Inc (NVAX)

Cash & Short-Term Investments

$719.34M

Quarterly · Period ending: · USD

NVAX logo

NVAX Cash & Short-Term Investments

Latest reported$719.34M
NVAX Quarterly Cash & Short-Term Investments ($3.90M → $719.34M)
High-resolution chart · PNG

NVAX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
719,340,000
790,332,000
735,084,000
762,894,000
612,304,000
731,479,000
923,118,000
909,531,000
1,049,594,000
480,586,000
568,505,000
651,104,000
505,912,000
624,950,000
1,336,883,000
1,280,581,000
1,375,587,000
1,570,954,000
1,515,116,000
1,936,998,000
2,074,880,000
1,997,732,000
711,047,000
504,031,000
502,297,000
237,355,000
78,823,000
71,167,000
71,995,000
100,195,000
70,154,000
127,108,000
167,111,000
143,760,000
106,307,000
172,566,000
187,308,000
211,178,000
144,353,000
300,283,000
366,362,000
132,225,000
230,656,000
290,186,000
167,384,000
327,735,000
168,056,000
178,090,000
152,456,000
112,828,000
133,068,000
146,410,000
40,599,000
9,023,000
44,111,000
28,410,000
26,536,000
20,720,000
18,309,000
19,604,000
22,321,000
23,923,000
31,676,000
36,863,000
26,786,000
32,888,000
42,950,000
34,375,000
31,194,000
25,587,000
33,900,000
45,244,000
35,885,000
40,893,000
46,489,000
52,260,000
61,216,000
67,629,000
73,595,000
75,145,000
78,601,000
83,941,000
31,893,000
6,944,000
4,442,000
9,202,000
17,876,000
27,503,000
15,623,000
21,885,000
27,633,000
6,045,000
9,625,000
14,320,000
3,005,000
7,630,000
15,927,000
10,885,000
20,045,000
23,296,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.